Pulmonary Drug Delivery Systems: Technologies and Global Markets
The global pulmonary drug delivery technologies market which was $19.6 billion in 2010 is expected to be around $22.5 billion by 2011. This global market is further projected to reach nearly $44 billion by 2016 at a compound annual growth rate (CAGR) of 14.3%.
SCOPE AND FORMAT
The report reviews global markets for drug delivery technologies and new developments, and forecasts trends for use of current devices for drug delivery and for safety and toxicology through 2016. The report presents important devices, technologies, and the latest developments, market share by device and disease type, current products on the market, market share by company or product, and statistical information for types of respiratory diseases prevalent worldwide, with special emphasis on the U.S. market. The report also includes current issues and trends affecting the industry including costs, and factors influencing demand will be discussed. The report covers products in development, new technologies, trends, alliances, patents, and mergers. The report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints, and opportunities.
Usha Nagavarapu is an experienced pharmaceutical professional with scientific and alliance development experience. She has more than 10 years of drug and device product development and alliance management experience. She has managed preclinical discovery programs from target identification through design of Phase I testing, including Investigational New Drug (IND)-enabling studies, and assisted out-licensing and portfolio development activities. Strong focus areas include oncology, dermatology, and cardiovascular diseases. She also has extensive experience working with early startups to fulfill operational obligations while minimizing overall operational cost and burdens.